HEMATOLOGY
January 14, 2022
Pharmacist Involvement in Antibody-Drug Conjugate Therapy
The 12 antibody-drug conjugates currently FDA approved to treat hematologic or solid malignancies are similar in structure and concept, but each has a unique indication and molecular target.August 12, 2020
Advances in the Management of Sickle Cell Disease
August 12, 2020
Hemophilia Review
August 12, 2020
Guest Editorial: Assuming the Front Line of ADR Reporting
April 29, 2020
Managing Coagulopathy Associated With COVID-19
February 27, 2020
Avoiding Infections in Immune-mediated Hematological Disorders
January 16, 2020
The Fundamentals of Managing Follicular Lymphoma
January 16, 2020
Glioma Database Incorporates Omics Information
January 16, 2020
Immune Thrombocytopenia Guidelines Updated
August 22, 2019
Ice Chips Prevent Hyperalgesia With Oxaliplatin
August 22, 2019
Enzalutamide and ADT Reduce Prostate Cancer Progression Risk
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2022 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.